The sequence of spontaneous EpsteinBarr virus activation was studied in P3HR-1 carrier cells and in P3HR-1(BrdU) cells made resistant to 5-bromodeoxyuridine. Virus activation was initiated during the normal cell cycle, and recruitment of additional virusactivated cells was prevented by the DNA inhibitors, I-/-D-arabinofuranosylcytosine and hydroxyurea. Virus activation was followed by synthesis of the early antigen complex in the absence of additional detectable DNA synthesis. Early antigen synthesis was followed by hydroxyurea-resistant synthesis of new DNA, which in the case of P3HR-l(BrdU) cells was characterized by the appearance of thymidine kinase. The newly synthesized DNA banded in neutral cesium chloride at peaks corresponding to normal human DNA and Epstein-Barr viral DNA. Synthesis of viral antigen was seen only in cells that had undergone hydroxyurea-resistant DNA synthesis.
The Epstein-Barr herpesvirus (EB virus) persists in human lymphoblastoid cells in a repressed state (1) . In some cell lines, the repressed viral genome undergoes spontaneous activationt resulting in a carrier culture where virus is synthesized in at least a portion of the cell population at any one time. In other cell lines ("virus negative"), the viral genome remains repressed (2, 3) , although activation with resultant virus synthesis can be effected by treatment of the cells with 5-bromodeoxyuridine (BrdU) (4, 5) or 5-iododeoxyuridine (6) .
The studies reported here concern the relationship between DNA synthesis and synthesis of virus-associated intracellular antigens after spontaneous activation of the EB viral genome.
MATERIALS AND METHODS
Cells and Media. The P3HR-1 cell line that is EB virus positive and made resistant to BrdU (1), P3HR-1(BrdU), was propagated in 250-ml plastic flasks (Falcon Plastics, Inc.) with growth medium (1) containing 100 ug of BrdU per ml. Manipulations were performed in subdued light. Control P3HR-1 cells were maintained in drug-free medium. Total and viable cell counts were determined visually by the trypan blue exclusion method. Cell cultures were tested routinely and found free of contamination by pleuropneumonia-like organisms and other contaminants. Immunofluorescence. The indirect immunofluorescence technique and cells fixed for 10 min in acetone at -20°were used.
Two human sera were used after determination of their specificity for the two major-EB virus-associated-intracellular antigen complexes detected by immunofluorescence. The specificity of the sera for the early antigen (EA) complex (6) was determined in two ways. The first used "virus-negative" Raji and NC-37 cells treated with BrdU for activation of the viral genome (4) . The EA complex is the first virus-specific intracellular antigen complex to appear, as detected by immunofluorescence, in BrdU-activated cells (manuscript in preparation). The second method, performed by Dr. G. Pearson, used Raji cells infected with EB virus. The predominant intracellular antigen(s) produced under these conditions is EA (7) . The specificity of the sera for the viral antigen (VCA) complex (8) was also determined in two ways. The VCA complex, in contrast to the EA complex, is known to include viral structural antigens. The first method for detection of VCA used P3HR-1 cells cocultivated with Vero cells (9) . These cocultivated P3HR-1 cells produce large amounts of VCA and contain many virus particles. The second method involved direct staining by immunoferritin of intracellular EB virus capsids (10 Autoradiography. Cells grown in the presence of isotope were examined for antigen production by immunofluorescence and for DNA synthesis by autoradiography as described (1) . Areas on the slides were photographed so that at least 30 and usually 50 antigen-positive cells of each sample were recorded for subsequent autoradiographic analysis. This involved photographic records of several thousand cells for each sample.
Incorporation of Isotopes into DNA. Cells grown in the presence of isotope were extracted, and acid-precipitable counts lag period. Second, maximum DNA synthesis in thymidine kinase-positive P3HR-1(BrdU) cells occurred during the first day after passage. Third, maximum DNA synthesis in thymidine kinase-negative P3HR-1(BrdU) cells and in all P3HR-1 cells occurred during the second day after passage.
Similar results were observed when "4C-labeled isotopes were substituted for 8H-labeled isotopes.
Effect of ara-C and hydroxyurea on DNA synthesis
The effect of ara-C and hydroxyurea on DNA synthesis was studied during the first and second days after passage of P3HR-1 and P3HR-1 (BrdU) cells in drug-free medium. These were the times of maximum DNA synthesis in virusactivated P3HR-1(BrdU) (day. The results (Fig. 1 ) indicated effective inhibition of DNA synthesis in P3HR-1 and P3HR-1 (BrdU) cells by ara-C concentrations of 0.1 jig/ml and greater (Fig. 1A) . Effective inhibition of DNA synthesis in all P3HR-1 cells and in thymidine kinase-negative P3HR-1(BrdU) cells was also observed with hydroxyurea concentrations of 1 mM and greater (Fig. 1B) . In contrast, DNA synthesis in thymidine kinasepositive P3HR-1(BrdU) cells was not inhibited at relatively high hydroxyurea concentrations, and isotope incorporation was actually enhanced at low drug concentrations (Fig. 1B ).
were determined as described (1) . Where indicated, cell extracts were treated for 30 min at 370 with either 50 ,ug of RNase per ml (heated at 1000 for 10 min) or 600 jug of DNase per ml in the presence of 0.02 M Mg++.
RESULTS
Preliminary studies were performed for determination of optimal conditions for propagation of P3HR-1(BrdU) cells to minimize asynchrony in the sequence of spontaneous EB virus activation and production of EA and VCA. The procedure finally selected involved passage, of cells at 7-to S-day intervals without refeeding. Under these conditions, maximum cell numbers were attained in 4-5 days and the cells remained in stationary phase for 2-3 days.
Synchrony of VCA production was obtained readily in P3HR-1(BrdU) cells maintained on 100 u4g of BrdU per ml, since this drug concentration effectively inhibited synthesis of virus particles and reduced synthesis of VCA detectable by immunofluorescence to very low concentrations. Removal of BrdU resulted in the reappearance of VCA (1 day) and virus particles (4 days The results (not shown) were as follows. First, replication of both P3HR-1 and P3HR-1 (BrdU) cells followed essentially the same course, reaching optimal rates after about a 2-day This was studied by immunofluorescence and autoradiography in the presence and absence of ara-C (5jsg/ml) and hydroxyurea (5 mM). Experiments were terminated after 4 days, at which time cell mortality (>90%) and degeneration caused by ara-C and hydroxyurea precluded further accurate determinations.
The results with [3H]dT-labeled cells stained with EA+, VCA+ serum ( Fig. 2A and 2C) were as follows. Antigenpositive cells were present in all cultures, but only control (drug-free) cultures showed a significant decline on days 273 in the percentage of antigen-positive cells (Fig. 2A) . This decline coincided with the time of first cell division. Throughout the experimental period, all isotope-labeled control and hydroxyurea-treated cells were also antigen positive (Fig. 2C) . Isotope labeling in these cells was heavy and was initially localized in the nucleus; with time, however, grains were seen throughout the whole cell. In antigen-positive multinucleated cells, heavy labeling was seen in all nuclei (Fig. 3A and B) . Grains were not detected in ara-C-treated cells (not shown). Finally, all antigen-positive control and hydroxyurea-treated cells were not necessarily labeled with isotope (Fig. 2C, 3C, and 3D) control and hydroxyurea-treated cells were evident (Fig. 2B) . No antigen-positive cells appeared in ara-C-treated cultures (Fig. 2B) . Throughout the experimental period, all antigenpositive control and hydroxyurea-treated cells showed isotope labeling (Fig. 2D) , but all isotope-labeled cells were not positive for antigen ( Fig. 3E and 3F) . Similar (1) . Second, hydroxyurea-treated cultures showed heavy isotope labeling that was restricted to antigen positive cells. Finally, ara-C-treated cultures showed no isotope labeled cells.
Based on the studies cited above, and assuming that the difference in the percentage of cells stained by the EA+, VCA+, and EA-, VCA+ sera represents EA synthesis, we conclude the following: First, EA synthesis precedes DNA synthesis in virus-activated cells. Second, DNA synthesis precedes VCA synthesis in virus-activated cells. Third, essentially all EApositive cells undergo some DNA synthesis, although VCA may not be made in all of these cells. Fourth, hydroxyurea selectively permits DNA synthesis and VCA production only in virus-activated cells. Finally, ara-C inhibits DNA synthesis and VCA production in all cells regardless of whether EA is present.
Relationship between DNA synthesis and activation of the EB viral genome
The synthesis of EA that follows activation of the EB viral genome is not inhibited by ara-C or hydroxyurea (ref. 11; Fig. 2A ). This suggests two possibilities to explain the relationship between DNA synthesis and EB virus activation. First, virus activation may occur independent of prior DNA synthesis. Under these conditions, spontaneous virus activation may occur in any cell in the presence of ara-C or hydroxyurea, with EA being synthesized after transcription of the "activated" DNA. A second possibility is that virus activation is determined during the normal cell cycle, and is limited at any one time to specific cells in the population. Under these conditions, EA synthesis in ara-C-or hydroxyurea-treated cells may still occur, but only by transcription of "activated" DNA in predetermined cells.
In order to study these two possibilities, a means was required for identification of virus-activated cells. One obvious marker of virus activation in P3HR-1 (BrdU) cells is the incorporation of dT. This marker, unfortunately, is seen only at a late stage after virus activation, as exemplified by the following observations. Fig. 2C The results with EA+, VCA+ serum ( Fig. 4A and C) and with EA-, VCA+ serum ( Fig. 4B and D) were similar, with over 90% of the antigen-positive cells being labeled at time 0. The percentage of antigen-positive isotope-labeled control cells declined progressively (Fig. 4C and D) , reflecting the appearance of newly activated cells; while cells in hydroxyureatreated cultures, but not in ara-C-treated cultures, showed only a small decline in the percentage of antigen-positive, labeled cells (Fig. 4C and D) .
We conclude from these studies that The inhibition of DNA synthesis by hydroxyurea in all but EB virus-activated cells is, to the best of our knowledge, the first example of a drug that selectively permits DNA synthesis in mammalian cells after activation of a repressed DNA viral genome. The DNA synthesized in hydroxyurea-treated cells is of more than one type, suggesting that the hydroxyurea-resistant pathways include steps preceding free "viral" DNA synthesis. The mechanism of action of hydroxyurea that accounts for the selective synthesis of DNA in EB virusactivated cells is unknown. It is known that DNA repair can proceed in the presence of hydroxyurea (12) . It is also known that hydroxyurea interferes with ribonucleotide reductase activity with resultant inhibition of DNA synthesis in mammalian systems (13) , including the P3HR-1 cell line (unpublished observations). Synthesis of infectious T4 bacteriophage in Escherichia coli has been observed in the presence of hydroxyurea (14) and ascribed to the use of cell DNA breakdown products. In hydroxyurea-treated human amnion cells infected with herpes simplex virus, synthesis of "early" viral products, including structural proteins, has been described in the absence of DNA synthesis (15) , and this has been ascribed to transcription of the input viral DNA.
Although similarities in the action of hydroxyurea in our system and those described above have yet to be determined, the findings reported here suggest that synthesis of new 
